Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075397 | SCV001241019 | uncertain significance | Retinal dystrophy | 2018-07-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001206811 | SCV001378140 | pathogenic | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 403 of the ABCA4 protein (p.Asp403Val). This variant is present in population databases (no rsID available, gnomAD 0.008%). This missense change has been observed in individual(s) with clinical features of Stargardt disease and/or Stargardt disease (PMID: 25066811; Invitae). ClinVar contains an entry for this variant (Variation ID: 866970). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ABCA4 protein function. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001206811 | SCV002097557 | uncertain significance | not provided | 2022-02-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25066811) |